Author

Domingo Acosta

Spanish National Cancer Research Centre

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Research Focus:perturbation response prediction· 1

Frequent Co-Authors

Alejandra López-GarcíaiD· 1 shared Blanca Rosas-PéreziD· 1 shared Bruno SáinziD· 1 shared Carmen E. GuerraiD· 1 shared Carmen G. LechugaiD· 1 shared Eduardo J. CaleirasiD· 1 shared Elena Zamorano-DomíngueziD· 1 shared Francisco Sanchez Bueno· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alejandra López-GarcíaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A TARGETED COMBINATION THERAPY ACHIEVES EFFECTIVE PANCREATIC CANCER REGRESSION AND PREVENTS TUMOR RESISTANCE

Vasiliki Liaki, Sara Barrambana, Myrto Kostopoulou, Carmen G. Lechuga, Elena Zamorano-Domínguez, Domingo Acosta, Lucía Morales-Cacho, Ruth Álvarez, Pian Sun, Blanca Rosas-Pérez, Rafael Barrero, Silvia Jiménez-Parrado, Alejandra López-García, Marta San Roman, Juan Carlos López-Gil, , Mariano Barbacid

This paper shows that combining three KRAS signaling pathway inhibitors effectively regresses pancreatic tumors and prevents resistance in preclinical models.

Proceedings of the National Academy of Sciences · Dec 2, 2025Peer-reviewedCancer Biology